NCT02409563View on ClinicalTrials.gov

Nasal Budesonide Efficacy on Nasal FeNO in Children With Allergic Rhinitis

PHASE4CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Allergic Rhinitis
Interventions
DRUG

Budesonide nasal spray (100 mcg bid)

DRUG

Budesonide nasal spray (50 mcg bid

Trial Locations (1)

90146

Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council, Palermo

All Listed Sponsors
lead

Istituto per la Ricerca e l'Innovazione Biomedica

OTHER

NCT02409563 - Nasal Budesonide Efficacy on Nasal FeNO in Children With Allergic Rhinitis | Biotech Hunter | Biotech Hunter